<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00445562</url>
  </required_header>
  <id_info>
    <org_study_id>GENBASIX-00127</org_study_id>
    <secondary_id>CDR0000529353</secondary_id>
    <secondary_id>GENBASIX-1024122</secondary_id>
    <nct_id>NCT00445562</nct_id>
  </id_info>
  <brief_title>Blood Sample Collection and Health Information Collection From Patients With Invasive Breast Cancer and Their Brothers and Sisters</brief_title>
  <official_title>Breast Cancer Siblings Database</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GenBasix Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute (NCI)</source>
  <brief_summary>
    <textblock>
      RATIONALE: Collecting blood samples and health information from patients with invasive breast
      cancer and from their brothers and sisters over time may help the study of cancer in the
      future.

      PURPOSE: This study is collecting blood samples and health information over time from
      patients with invasive breast cancer and from their brothers and sisters.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

        -  Collect blood samples and medical and background information from patients with invasive
           breast cancer and their affected or unaffected siblings.

      OUTLINE: Patients and their siblings undergo blood collection. They also complete medical and
      background questionnaires.

      Patients and their siblings are followed annually for 5 years.

      PROJECTED ACCRUAL: A total of 1,000 patients and siblings will be accrued for this study.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2001</start_date>
  <primary_completion_date type="Actual">December 2004</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>Collection of blood samples and medical and background information</measure>
  </primary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Breast Cancer</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>biologic sample preservation procedure</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>informational intervention</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Meets 1 of the following criteria:

               -  Pathologically confirmed invasive breast cancer (patient)

                    -  No ductal carcinoma in situ

               -  Affected OR unaffected sibling

                    -  Affected sibling must have had (or currently has) breast cancer only

                    -  Unaffected sibling must be female

                    -  No deceased siblings

                    -  Must be a full-blood related sibling

          -  Patients receiving treatment on clinical trial ECOG-E1Y97 or ECOG-E3Y92 are not
             eligible

        PATIENT CHARACTERISTICS:

          -  Not specified

        PRIOR CONCURRENT THERAPY:

          -  Not specified
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard A. Shapiro, MD</last_name>
    <role>Study Chair</role>
    <affiliation>GenBasix Incorporated</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GenBasix Incorporated</name>
      <address>
        <city>Duarte</city>
        <state>California</state>
        <zip>91010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard A. Shapiro, MD</last_name>
      <phone>800-248-4908</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2007</study_first_submitted>
  <study_first_submitted_qc>March 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2007</study_first_posted>
  <last_update_submitted>July 9, 2013</last_update_submitted>
  <last_update_submitted_qc>July 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 10, 2013</last_update_posted>
  <keyword>male breast cancer</keyword>
  <keyword>recurrent breast cancer</keyword>
  <keyword>stage IA breast cancer</keyword>
  <keyword>stage IB breast cancer</keyword>
  <keyword>stage II breast cancer</keyword>
  <keyword>stage IIIA breast cancer</keyword>
  <keyword>stage IIIB breast cancer</keyword>
  <keyword>stage IIIC breast cancer</keyword>
  <keyword>stage IV breast cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

